Aquestive Therapeutics (NASDAQ:AQST) just reported results for the first quarter of 2024.
- Aquestive Therapeutics reported earnings per share of -17 cents. This was below the analyst estimate for EPS of -8 cents.
- The company reported revenue of $12.05 million.
- This was 1.69% worse than the analyst estimate for revenue of $12.26 million.